UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
December 17, 2007 (December 17, 2007)
____________
DIALYSIS CORPORATION OF AMERICA
(Exact name of registrant as specified in its charter)
Florida 0-8527 59-1757642
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
1302 Concourse Drive, Suite 204, Linthicum, MD 21090
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (410) 694-0500
____________
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement
On October 24, 2005, Dialysis Corporation of America (the "Company")
entered into a Credit Agreement with Keybank National Association
("Keybank"), pursuant to which Keybank has provided the Company with a $15
million secured revolving credit facility (the "Credit Agreement") by means
of any combination of base rate loans and/or LIBOR loans. The Credit
Agreement was reported in a Current Report on Form 8-K dated October 27,
2005. Keybank and the Company entered into Amendment No. 4 to the Credit
Agreement to extend the Credit Agreement for an additional year through
October 24, 2009, and to provide for an aggregate of $10,000,000 in Permitted
Acquisitions after January 1, 2008. A Permitted Acquisition is defined in
the Credit Agreement primarily as an acquisition of dialysis operations or
services.
The proceeds of the Credit Agreement are used for development and
acquisition of new dialysis centers, working capital needs, and for other
general corporate purposes.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation Under an
Off-Balance Sheet Arrangement of a Registrant
The information relating to the Company's entry into Amendment No. 4 to
Credit Agreement is set forth in Item 1.01 above, and is incorporated in this
Item 2.03 by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
(10) Material Contracts
(i) Amendment No. 4 to Credit Agreement between the Company and
Keybank National Association dated December 17, 2007
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
DIALYSIS CORPORATION OF AMERICA
/s/ Stephen W. Everett
By______________________________
STEPHEN W. EVERETT
President and Chief Executive Officer
Dated: December 17, 2007
EXHIBIT INDEX
Exhibit
Number
- --------
(10) Material Contracts
(i) Amendment No. 4 to the Credit Agreement between the Company and
Keybank National Association dated December 17, 2007